U.S., Jan. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07369232) titled 'Cerebral Hemodynamic Effects of Oxygen and Antioxidants (CHEOXANT)' on Sept. 18, 2025.
Brief Summary: This study is called CHE-OX-ANT (Cerebral Hemodynamic Effects of Oxygen and Antioxidants). It is a single-center, academic research project led by the Department of Intensive Care at Erasme Hospital (Universite Libre de Bruxelles).
The study focuses on understanding how the brain and blood vessels react when a person breathes pure oxygen and how these effects may be influenced by giving vitamin C, an antioxidant. Oxygen is one of the most common treatments in hospitals. While it can be life-saving, too much oxygen may sometimes cau...